Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Arrhythmias

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 62 articles: HTML format

Single Articles

November 2025
1. CHATTERJEE NA
   Targeting Potassium for Prevention of Ventricular Arrhythmias.
   N Engl J Med. 2025;393:2047-2048.
   PubMed    
   
   
   
2. SCHWARTZ PJ, Crotti L
   Long QT Syndrome.
   N Engl J Med. 2025;393:2023-2034.
   PubMed    
   
   
   
3. VERMA A, Birnie DH, Jiang C, Heidbuchel H, et al
   Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation.
   N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2509688.
   PubMed     Abstract available
   
   
   
4. LEE SJ, Yu HT, Lee YJ, Lee SH, et al
   Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.
   N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2512091.
   PubMed     Abstract available
   
   
   August 2025
5. JONS C, Zheng C, Winslow UCG, Danielsen EM, et al
   Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias.
   N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2509542.
   PubMed     Abstract available
   
   
   July 2025
6. REICHLIN T, Juni P, Sticherling C
   Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation. Reply.
   N Engl J Med. 2025;393:519-520.
   PubMed    
   
   
   
7. CHEN M, Li X, Zhou S
   Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
   N Engl J Med. 2025;393:519.
   PubMed    
   
   
   
8. KARAKASIS P, Fragakis N
   Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
   N Engl J Med. 2025;393:518-519.
   PubMed    
   
   
   
9. BLACKWELL JN, Wang NC, Bhonsale A
   Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
   N Engl J Med. 2025;393:518.
   PubMed    
   
   
   
10. MCFARLAND R, Hyslop LA, Feeney C, Pillai RN, et al
    Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease.
    N Engl J Med. 2025;393:461-468.
    PubMed     Abstract available
    
    
    
11. WAZNI OM, Roy K
    Atrial Appendage Closure after Ablation for Atrial Fibrillation. Reply.
    N Engl J Med. 2025;393:202-203.
    PubMed    
    
    
    
12. LEON-ACUNA IG
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:202.
    PubMed    
    
    
    
13. PIMENTEL M
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:201-202.
    PubMed    
    
    
    
14. OCCHIPINTI G, Brugaletta S, Sabate M
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:201.
    PubMed    
    
    
    
15. BYUN JH
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:201.
    PubMed    
    
    
    
16. TAM MTK, Chan JYS, So KCY
    Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2025;393:200-201.
    PubMed    
    
    
    May 2025
17. GOREY S, Healey JS, Kirchhof P
    Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation.
    N Engl J Med. 2025;392:1749-1751.
    PubMed    
    
    
    April 2025
18. RUFF CT, Goodrich EL, Sabatine MS
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. Reply.
    N Engl J Med. 2025;392:1557.
    PubMed    
    
    
    
19. RASCHI E, Squizzato A
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1556-1557.
    PubMed    
    
    
    
20. HENRY C
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1556.
    PubMed    
    
    
    March 2025
21. REICHLIN T, Kueffer T, Badertscher P, Juni P, et al
    Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2502280.
    PubMed     Abstract available
    
    
    
22. PICCINI JP, Patel MR, Caso V
    Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply.
    N Engl J Med. 2025;392:1247-1248.
    PubMed    
    
    
    
23. BENKHOFF M, Mourikis P, Polzin A
    Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1247.
    PubMed    
    
    
    
24. STRAW S, Witte KK, Philippou H
    Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:1246-1247.
    PubMed    
    
    
    February 2025
25. CHO MS, Nam GB, Park DW
    Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease. Reply.
    N Engl J Med. 2025;392:826-827.
    PubMed    
    
    
    
26. SHIMAZU Y
    Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2025;392:826.
    PubMed    
    
    
    
27. GREMMEL T
    Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2025;392:826.
    PubMed    
    
    
    January 2025
28. RUFF CT, Patel SM, Giugliano RP, Morrow DA, et al
    Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2025;392:361-371.
    PubMed     Abstract available
    
    
    November 2024
29. WAZNI OM, Saliba WI, Nair DG, Marijon E, et al
    Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2408308.
    PubMed     Abstract available
    
    
    
30. SAPP JL, Tang ASL, Parkash R, Stevenson WG, et al
    Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2409501.
    PubMed     Abstract available
    
    
    
31. RUBIN EJ, Leopold J, Morrissey S
    NEJM at AHA - Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMe2414475.
    PubMed    
    
    
    
32. RUBIN EJ, Leopold J, Morrissey S
    NEJM at AHA - Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMe2414471.
    PubMed    
    
    
    October 2024
33. KNOPS RE, Lloyd MS, Roberts PR, Wright DJ, et al
    A Modular Communicative Leadless Pacing-Defibrillator System.
    N Engl J Med. 2024;391:1402-1412.
    PubMed     Abstract available
    
    
    September 2024
34. RUBIN EJ, Leopold J, Morrissey S
    NEJM at ESC - Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2410902.
    PubMed    
    
    
    
35. RUBIN EJ, Leopold J, Morrissey S
    NEJM at ESC - Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2410903.
    PubMed    
    
    
    
36. LIP GYH
    Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMe2409696.
    PubMed    
    
    
    
37. PICCINI JP, Patel MR, Steffel J, Ferdinand K, et al
    Asundexian versus Apixaban in Patients with Atrial Fibrillation.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMoa2407105.
    PubMed     Abstract available
    
    
    
38. CHO MS, Kang DY, Ahn JM, Yun SC, et al
    Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease.
    N Engl J Med. 2024 Sep 1. doi: 10.1056/NEJMoa2407362.
    PubMed     Abstract available
    
    
    May 2024
39. CONNOLLY SJ, Sharma M, Cohen AT, Demchuk AM, et al
    Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.
    N Engl J Med. 2024;390:1745-1755.
    PubMed     Abstract available
    
    
    April 2024
40. KUROLAP A, Chai Gadot C, Baris Feldman H
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis. Reply.
    N Engl J Med. 2024;390:1539-1540.
    PubMed    
    
    
    
41. ABASSI Z, Azzam ZS, Heyman SN
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1539.
    PubMed    
    
    
    
42. GLADYSHEVA IP, Wang D, Reed GL
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1538-1539.
    PubMed    
    
    
    
43. DOMINY J, Koch C, Lamarche L, Denning D, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1537-1538.
    PubMed    
    
    
    
44. HEALEY JS, Lopes RD
    Stroke Prevention in Subclinical Atrial Fibrillation. Reply.
    N Engl J Med. 2024;390:1442.
    PubMed    
    
    
    
45. ALLEN AL, Kibert J 2nd, Wall TS
    Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2024;390:1441-1442.
    PubMed    
    
    
    
46. LEE TC, Kaul S, Mandrola J
    Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2024;390:1441.
    PubMed    
    
    
    
47. LI S, Lip GYH, Ko D, Walkey A, et al
    Anticoagulation for Secondary Atrial Fibrillation.
    N Engl J Med. 2024;390:1237-1240.
    PubMed    
    
    
    March 2024
48. BUNCH TJ
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply.
    N Engl J Med. 2024;390:1056.
    PubMed    
    
    
    
49. REDDY VY, Gerstenfeld EP, Mansour M
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply.
    N Engl J Med. 2024;390:1055-1056.
    PubMed    
    
    
    
50. WOODS C, Schricker A, Hao S
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2024;390:1055.
    PubMed    
    
    
    
51. FRANCESCHI F, Maille B
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2024;390:1054-1055.
    PubMed    
    
    
    
52. DHAWAN R, Bikmal A
    Pulsed Field Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med. 2024;390:1054.
    PubMed    
    
    
    December 2023
53. SOHNS C, Tijssen JGP, Sommer P
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. Reply.
    N Engl J Med. 2023;389:2496-2497.
    PubMed    
    
    
    
54. KERLEY RN, Joyce E
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023;389:2495-2496.
    PubMed    
    
    
    
55. BLACKWELL JN, Olshansky B, Estes NAM 3rd
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023;389:2495.
    PubMed    
    
    
    November 2023
56. HEALEY JS, Lopes RD, Granger CB, Alings M, et al
    Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2023 Nov 12. doi: 10.1056/NEJMoa2310234.
    PubMed     Abstract available
    
    
    
57. SVENNBERG E
    What Lies beneath the Surface - Treatment of Subclinical Atrial Fibrillation.
    N Engl J Med. 2023 Nov 12. doi: 10.1056/NEJMe2311558.
    PubMed    
    
    
    
58. BUNCH TJ
    Hope, Hype, and Reality of Pulsed Field Ablation for Atrial Fibrillation.
    N Engl J Med. 2023;389:1720-1721.
    PubMed    
    
    
    
59. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2023;389:1685-1692.
    PubMed     Abstract available
    
    
    October 2023
60. LEWIS EF
    Catheter Ablation for Atrial Fibrillation in Heart Failure - An Option to Defer Transplantation?
    N Engl J Med. 2023;389:1429-1430.
    PubMed    
    
    
    September 2023
61. STONE PH, Sauer WH
    Harnessing the Deluge of Rhythm-Monitoring Data for the Prevention of Stroke.
    N Engl J Med. 2023;389:1232-1234.
    PubMed    
    
    
    August 2023
62. KIRCHHOF P, Toennis T, Goette A, Camm AJ, et al
    Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
    N Engl J Med. 2023 Aug 25. doi: 10.1056/NEJMoa2303062.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.